Institutional Ownership and Concentration of Capital in Pharmaceutical Companies: Evidence from Iran

Rouhollah Yaghoubi, Sara Emamgholipour, Amin Mohammadi, Bashir Azimi Nayebi, Abdoreza Mousavi, Fakhraddin Dastari
{"title":"Institutional Ownership and Concentration of Capital in Pharmaceutical Companies: Evidence from Iran","authors":"Rouhollah Yaghoubi, Sara Emamgholipour, Amin Mohammadi, Bashir Azimi Nayebi, Abdoreza Mousavi, Fakhraddin Dastari","doi":"10.18502/jebhpme.v7i4.15480","DOIUrl":null,"url":null,"abstract":"Background: Institutional owners influence the direction of policy and the performance of owned companies. This research was motivated by the presence of pharmaceutical companies in the Tehran Stock Exchange and the uncertainty surrounding the extent and influence of institutional owners on the policy direction and performance of the companies. \nMethods: This was a descriptive-analytical and cross-sectional study. The descriptive phase of the study involved measuring sales figures, market value, and market share of pharmaceutical companies listed on the stock exchange. In the analytical phase, the network of shareholders' relationships was analyzed with Gephi version 0.1 and Microsoft Excel version 2016, followed by the calculation of the capital concentration index and market share. \nResults: Estimates indicated that approximately 45% of the pharmaceutical companies in Iran were publicly traded in stock exchange. In 2020, the total value of these companies in the Iranian capital market reached 9.79 billion USD. Out of this amount, 45% (equivalent to 4.4 billion USD) was offered in Tehran Stock Exchange. The concentration of final shareholders, with a Herfindahl–Hirschman index(HHI) index of 0.036, signified a monopolistic competition market. On the other hand, the pharmaceutical capital market could be classified as an oligopoly market (with a value of 58.3) when analyzing only the direct shareholders at level 2. Additionally, the six main holding companies at this level collectively possess 67% of the pharmaceutical capital market. \nConclusion: Based on the results, the importance of institutional owners, such as the Social Security Organization (SSO), in the decision-making process regarding the Iranian pharmaceutical market can be acknowledged. The decisions about integration and supply chains which aimed at improving the productivity of the pharmaceutical market, need to be thoroughly examined by the institutions mentioned in this research.","PeriodicalId":198049,"journal":{"name":"Evidence Based Health Policy, Management and Economics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence Based Health Policy, Management and Economics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/jebhpme.v7i4.15480","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Institutional owners influence the direction of policy and the performance of owned companies. This research was motivated by the presence of pharmaceutical companies in the Tehran Stock Exchange and the uncertainty surrounding the extent and influence of institutional owners on the policy direction and performance of the companies. Methods: This was a descriptive-analytical and cross-sectional study. The descriptive phase of the study involved measuring sales figures, market value, and market share of pharmaceutical companies listed on the stock exchange. In the analytical phase, the network of shareholders' relationships was analyzed with Gephi version 0.1 and Microsoft Excel version 2016, followed by the calculation of the capital concentration index and market share. Results: Estimates indicated that approximately 45% of the pharmaceutical companies in Iran were publicly traded in stock exchange. In 2020, the total value of these companies in the Iranian capital market reached 9.79 billion USD. Out of this amount, 45% (equivalent to 4.4 billion USD) was offered in Tehran Stock Exchange. The concentration of final shareholders, with a Herfindahl–Hirschman index(HHI) index of 0.036, signified a monopolistic competition market. On the other hand, the pharmaceutical capital market could be classified as an oligopoly market (with a value of 58.3) when analyzing only the direct shareholders at level 2. Additionally, the six main holding companies at this level collectively possess 67% of the pharmaceutical capital market. Conclusion: Based on the results, the importance of institutional owners, such as the Social Security Organization (SSO), in the decision-making process regarding the Iranian pharmaceutical market can be acknowledged. The decisions about integration and supply chains which aimed at improving the productivity of the pharmaceutical market, need to be thoroughly examined by the institutions mentioned in this research.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
制药公司的机构所有权与资本集中:来自伊朗的证据
背景:机构所有者会影响所拥有公司的政策方向和业绩。本研究的动机是德黑兰证券交易所中的制药公司,以及机构所有者对公司政策方向和业绩的影响程度和影响的不确定性。研究方法:这是一项描述性分析和横截面研究。研究的描述性阶段包括测量在证券交易所上市的制药公司的销售数字、市场价值和市场份额。在分析阶段,使用 Gephi 0.1 版和 Microsoft Excel 2016 版分析股东关系网络,然后计算资本集中指数和市场份额。结果显示估计表明,伊朗约有 45% 的制药公司在证券交易所公开交易。2020 年,这些公司在伊朗资本市场的总价值达到 97.9 亿美元。其中,45%(相当于 44 亿美元)在德黑兰证券交易所发行。最终股东的集中度(赫芬达尔-赫希曼指数(HHI)为 0.036)表明市场处于垄断竞争状态。另一方面,如果只分析第 2 层的直接股东,医药资本市场可归类为寡头垄断市场(数值为 58.3)。此外,该层次的六家主要控股公司合计拥有医药资本市场 67% 的份额。结论根据研究结果,社会保障组织(SSO)等机构所有者在伊朗医药市场决策过程中的重要性不言而喻。有关整合和供应链的决策旨在提高医药市场的生产力,需要由本研究中提到的机构进行彻底审查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Measuring and Comparing Service Delivery Time in Government and Outsourced Health Posts Affiliated with Tehran University of Medical Sciences Evaluating the Effectiveness of Using Virtual Reality Interventions on Children and Adolescents with Autism Spectrum Disorder: A Systematic Review Institutional Ownership and Concentration of Capital in Pharmaceutical Companies: Evidence from Iran Factors Affecting the Resilience of Nurses in the COVID-19 Crisis: A Mixed Method Study from West of Iran Disaster Mitigation and preparedness from the Perspective of Holy Quran
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1